Evidence map›Paper›PMID 25992544›Full record

ArticleNature2015

Cardiac lymphatics are heterogeneous in origin and respond to injury.

Linda Klotz, Sophie Norman, Joaquim Miguel Vieira, Megan Masters, Mala Rohling, Karina N Dubé, Sveva Bollini, Fumio Matsuzaki, Carolyn A Carr, Paul R Riley

Open access · greenAbstract read
In one paragraph

Article in Nature, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 308 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
308citing papers in PubMed, 2 pooled it
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

308 citing papers in PubMed, 2 syntheses or guidelines pooled it, 502 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Angiogenic Doping: Plausible Yet Difficult to Detect.Sports medicine (Auckland, N.Z.) · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Signal control during tissue regeneration in adult animals.Nature reviews. Molecular cell biology · 2026
    Review
  17. Review
  18. Review
  19. Review
  20. Cardiac Lymphatics Predict Survival After Heart Transplantation.Journal of the American Heart Association · 2026
    Article

248 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Linda Klotz
Sophie Norman
Joaquim Miguel Vieira
Megan Masters
Mala Rohling
Karina N Dubé
Sveva Bollini
Fumio Matsuzaki
Carolyn A Carr
Paul R Riley
University of Oxford · GBUniversity College London · GBRIKEN Center for Biosystems Dynamics Research · JPUniversity of Genoa · IT

Funding

British Heart Foundation CH/11/1/28798British Heart Foundation PG/13/34/30216British Heart Foundation RG/08/003/25264British Heart Foundation RG/13/9/30269British Heart Foundation RM/13/3/30159Wellcome Trust
6 · The paper itself

Abstract

The lymphatic vasculature is a blind-ended network crucial for tissue-fluid homeostasis, immune surveillance and lipid absorption from the gut. Recent evidence has proposed an entirely venous-derived mammalian lymphatic system. By contrast, here we show that cardiac lymphatic vessels in mice have a heterogeneous cellular origin, whereby formation of at least part of the cardiac lymphatic network is independent of sprouting from veins. Multiple Cre–lox-based lineage tracing revealed a potential contribution from the putative haemogenic endothelium during development, and discrete lymphatic endothelial progenitor populations were confirmed by conditional knockout of Prox1 in Tie2+ and Vav1+ compartments. In the adult heart, myocardial infarction promoted a significant lymphangiogenic response, which was augmented by treatment with VEGF-C, resulting in improved cardiac function. These data prompt the re-evaluation of a century-long debate on the origin of lymphatic vessels and suggest that lymphangiogenesis may represent a therapeutic target to promote cardiac repair following injury.

Indexed as

LymphangiogenesisAnimalsCell LineageEndothelial CellsFemaleHeartHomeodomain ProteinsLymphatic VesselsMaleMiceMice, Inbred C57BLMyocardial InfarctionMyocardiumProspero-Related Homeobox 1 ProteinProto-Oncogene Proteins c-vavReceptor, Macrophage Colony-Stimulating FactorHomeodomain ProteinsProspero-Related Homeobox 1 ProteinProto-Oncogene Proteins c-vavReceptor, Macrophage Colony-Stimulating FactorReceptor, Platelet-Derived Growth Factor betaReceptor, TIE-2Tek protein, mouseTumor Suppressor ProteinsVascular Endothelial Growth Factor CVav1 protein, mouse

Identifiers

PMID25992544
PMCPMC4458138
OpenAlexW1568237782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.